Drug Pipeline

Cabergoline Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07386080 Carbergoline for Antipsychotic Induced Hyperprolactinemia. Scizophrenia Not Yet Recruiting
Phase 3
NCT07463235 Safety and Potency of a High Cabergoline Dosage in Microprolactinomas Prolactinoma Recruiting
Phase 2
NCT07043322 Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence… Gynecologic Disease Recruiting
NCT07492160 Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms Pregnancy Recruiting
Not specified
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Cabergoline Trials
Tanta University (1) Zealand University Hospital (1) University of Sao Paulo General Hospital (1) Maimonides Medical Center (1) Enhanced Emirates Limited (1)
Get alerts when Cabergoline trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free